These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9580850)

  • 21. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.
    McDougall IR
    Thyroid; 2009 Aug; 19(8):811-3. PubMed ID: 19645613
    [No Abstract]   [Full Text] [Related]  

  • 22. Advancements in the diagnosis and treatment of differentiated thyroid cancer.
    Stack BC
    Clin Med Res; 2003 Jan; 1(1):3. PubMed ID: 15931277
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic I-123 scintigraphy to assess potential breast uptake of I-131 before radioiodine therapy in a postpartum woman with thyroid cancer.
    Hsiao E; Huynh T; Mansberg R; Bautovich G; Roach P
    Clin Nucl Med; 2004 Aug; 29(8):498-501. PubMed ID: 15249829
    [No Abstract]   [Full Text] [Related]  

  • 24. Scintigraphic control of radioiodine 131-I distribution following administration of therapeutic dose for a differentiated cancer of the thyroid gland.
    Röhling S; Nĕmec J; Zamrazil V; Pohunková D; Jezek V
    Czech Med; 1983; 6(2):125-6. PubMed ID: 6409563
    [No Abstract]   [Full Text] [Related]  

  • 25. Radioiodine ablation outcomes after imaging with 123I or 131I: is no news good news?
    Burniston MT; Wilson DJ
    J Nucl Med; 2008 Jan; 49(1):166; author reply 166-7. PubMed ID: 18165699
    [No Abstract]   [Full Text] [Related]  

  • 26. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
    Dam HQ; Kim SM; Lin HC; Intenzo CM
    Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative uptake in the thyroid bed, not tumor stage, determines the usefulness of diagnostic whole body scan in the first year after ablation with radioiodine.
    Rosário PW; Barroso AL; Purisch S
    Thyroid; 2007 Aug; 17(8):803-4. PubMed ID: 17708716
    [No Abstract]   [Full Text] [Related]  

  • 28. The low utility of pretherapy scans in thyroid cancer patients.
    Schlumberger MJ; Pacini F
    Thyroid; 2009 Aug; 19(8):815-6. PubMed ID: 19645614
    [No Abstract]   [Full Text] [Related]  

  • 29. What is the best strategy to treat and study patients after near-total thyroidectomy?
    Sarmiento AJ; Sarmiento FM; Sarmiento AH
    J Nucl Med; 2001 Mar; 42(3):531-3. PubMed ID: 11337535
    [No Abstract]   [Full Text] [Related]  

  • 30. Thyroid carcinoma metastatic to pituitary.
    Sziklas JJ; Mathews J; Spencer RP; Rosenberg RJ; Ergin MT; Bower BF
    J Nucl Med; 1985 Sep; 26(9):1097. PubMed ID: 4032051
    [No Abstract]   [Full Text] [Related]  

  • 31. Stunned thyroid after a diagnostic dose of I-131 for a whole body scan.
    Kao CH
    Clin Nucl Med; 1998 Feb; 23(2):102-4. PubMed ID: 9481500
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effective I-131 therapy in metastasis of thyroid cancer to the cervical vertebrae; a case report].
    Fujiwara K; Endo K; Iwasaki Y; Hosono M; Konishi J; Torizuka K; Seki M
    Rinsho Hoshasen; 1986 Sep; 31(9):1045-8. PubMed ID: 3784042
    [No Abstract]   [Full Text] [Related]  

  • 33. A Case of Radioactive Iodine Uptake Found in Artificial Eye.
    Kim IH; Yoon JK; Lee SJ; Jeong E; An YS
    Clin Nucl Med; 2019 Apr; 44(4):317-318. PubMed ID: 30762819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal uptake of I-131 mimicking salivary gland uptake in a patient with diffuse dental disease.
    Morgan R; Cote M
    Clin Nucl Med; 2000 Apr; 25(4):314-5. PubMed ID: 10750985
    [No Abstract]   [Full Text] [Related]  

  • 35. [Iodine scintigraphy of differentiated thyroid carcinoma].
    Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
    Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
    [No Abstract]   [Full Text] [Related]  

  • 36. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
    Cholewinski SP; Yoo KS; Klieger PS; O'Mara RE
    J Nucl Med; 2000 Jul; 41(7):1198-202. PubMed ID: 10914909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
    Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
    Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
    [No Abstract]   [Full Text] [Related]  

  • 38. [Parotid gland function following radioiodine therapy of thyroid cancer based on data from radionuclide sialoscintigraphy].
    Sorokin IN; Prikhod'ko AG
    Stomatologiia (Mosk); 1987; 66(2):50-2. PubMed ID: 3033850
    [No Abstract]   [Full Text] [Related]  

  • 39. Radioactive iodine scanning and treatment in management of Hürthle cell thyroid carcinoma.
    Caplan RH
    Endocr Pract; 2006; 12(3):342; author reply 342. PubMed ID: 16772210
    [No Abstract]   [Full Text] [Related]  

  • 40. Do we read carefully?
    Medvedec M
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):475-6. PubMed ID: 12634977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.